KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Boston Scientific (BSX) Equity Ratio (2016 - 2026)

Boston Scientific's Equity Ratio history spans 18 years, with the latest figure at 0.59 for Q1 2026.

  • On a quarterly basis, Equity Ratio rose 5.25% to 0.59 in Q1 2026 year-over-year; TTM through Mar 2026 was 0.59, a 5.25% increase, with the full-year FY2025 number at 0.55, changed 0.41% from a year prior.
  • Equity Ratio hit 0.59 in Q1 2026 for Boston Scientific, up from 0.55 in the prior quarter.
  • Over the last five years, Equity Ratio for BSX hit a ceiling of 0.62 in Q1 2022 and a floor of 0.07 in Q2 2023.
  • Historically, Equity Ratio has averaged 0.37 across 5 years, with a median of 0.55 in 2024.
  • Biggest five-year swings in Equity Ratio: skyrocketed 112560.73% in 2022 and later crashed 414.48% in 2025.
  • Tracing BSX's Equity Ratio over 5 years: stood at 0.02 in 2022, then surged by 2506.34% to 0.56 in 2023, then dropped by 0.58% to 0.55 in 2024, then increased by 0.41% to 0.55 in 2025, then rose by 6.07% to 0.59 in 2026.
  • Business Quant data shows Equity Ratio for BSX at 0.59 in Q1 2026, 0.55 in Q4 2025, and 0.55 in Q3 2025.